Financial
News release
TopTOKYO, JAPAN – September 16, 2022 – Associates of Terumo Corporation (TSE: 4543) today celebrated “Terumo Patient’s Day 2022” to connect with Terumo’s Group Mission “Contributing to Society through Healthcare”, and for each associate to reconfirm their day-to-day contribution at work ultimately leads to the well-being of patients.
Terumo Patient’s Day originally started in 2013, and this is the ninth year of celebration. Terumo Patient’s Day is celebrated globally throughout the Terumo Group. Every year, various activities to engage with medical settings are held such as healthcare provider and patient speaker events, visits to hospitals, and blood donation drives.
For associates working at Terumo Corporation in Japan, in the past, events on themes such as cancer, heart disease, kidney disease, blood transfusion, and nursing have been held. This year, talk sessions on diabetes took place, featuring a doctor and a person with type 1 diabetes as speaker guests.
Shinjiro Sato, CEO of Terumo Corporation comments, “Terumo has 28,000 steadfast associates gathered from around the world resonating with our Group Mission and Core Values. Many associates may not have direct interaction with medical settings in the course of daily work. But without a doubt, each of our jobs finds its way to patients, in the form of ‘solutions’ we provide through our products and services. I hope that each and every Terumo Associates feel proud and continue the very important work that each of us is responsible for. As a company, our Purpose is to advance healthcare and enhancing patients’ quality of life.”
Terumo Patient’s Day originally started in 2013, and this is the ninth year of celebration. Terumo Patient’s Day is celebrated globally throughout the Terumo Group. Every year, various activities to engage with medical settings are held such as healthcare provider and patient speaker events, visits to hospitals, and blood donation drives.
For associates working at Terumo Corporation in Japan, in the past, events on themes such as cancer, heart disease, kidney disease, blood transfusion, and nursing have been held. This year, talk sessions on diabetes took place, featuring a doctor and a person with type 1 diabetes as speaker guests.
Shinjiro Sato, CEO of Terumo Corporation comments, “Terumo has 28,000 steadfast associates gathered from around the world resonating with our Group Mission and Core Values. Many associates may not have direct interaction with medical settings in the course of daily work. But without a doubt, each of our jobs finds its way to patients, in the form of ‘solutions’ we provide through our products and services. I hope that each and every Terumo Associates feel proud and continue the very important work that each of us is responsible for. As a company, our Purpose is to advance healthcare and enhancing patients’ quality of life.”
About Terumo
Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of “Contributing to Society through Healthcare.” Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.